lorundrostat
lorundrostat: developed by 1 company · 1 clinical trial tracked · 1 FDA decision. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Mineralys Therapeutics, Inc. (MLYS) | Phase 2 |
Clinical Trials (1)
An Open-Label Extension Study to Assess the Long-Term Safety, Efficacy, and Tolerability of Lorundrostat in Subjects With Hypertension
FDA Decisions
PDUFAadult patients with hypertension in combination with other antihypertensive drugs had been accepted(MLYS)
Frequently asked questions
Who is developing lorundrostat?
lorundrostat is being developed by Mineralys Therapeutics, Inc..
How many clinical trials involve lorundrostat?
BioSniper tracks 1 clinical trial involving lorundrostat.
What is lorundrostat's latest FDA decision?
The most recent tracked FDA decision for lorundrostat is PDUFA for adult patients with hypertension in combination with other antihypertensive drugs had been accepted.
Get deeper analysis on lorundrostat
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis